These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15070128)

  • 1. Abnormal coagulation studies associated with levofloxacin. Report of three cases.
    Psarros T; Trammell T; Morrill K; Giller C; Morgan H; Allen B
    J Neurosurg; 2004 Apr; 100(4):710-2. PubMed ID: 15070128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin.
    Norrby SR
    Expert Opin Pharmacother; 1999 Nov; 1(1):109-19. PubMed ID: 11249554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of levofloxacin 200 mg 3 times daily in the treatment of bacterial lower respiratory tract infections.
    Kawai T
    Drugs; 1995; 49 Suppl 2():416-7. PubMed ID: 8549383
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections.
    Shishido H; Furukawa K; Nagai H; Kawakami K; Kono H
    Drugs; 1995; 49 Suppl 2():433-5. PubMed ID: 8549391
    [No Abstract]   [Full Text] [Related]  

  • 6. Levofloxacin-induced toxic epidermal necrolysis in an elderly patient.
    Digwood-Lettieri S; Reilly KJ; Haith LR; Patton ML; Guilday RJ; Cawley MJ; Ackerman BH
    Pharmacotherapy; 2002 Jun; 22(6):789-93. PubMed ID: 12066972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections.
    Nakamori Y; Miyashita Y; Nakatani I; Nakata K
    Drugs; 1995; 49 Suppl 2():418-9. PubMed ID: 8549384
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient.
    Schwalm JD; Lee CH
    CMAJ; 2003 Apr; 168(7):847-8. PubMed ID: 12668542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse drug reaction and rational use of levofloxacin: a prospective study].
    Zhang Z; Zhen J; Zhan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Dec; 22(6):405-7. PubMed ID: 11851050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ
    Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin-associated Achilles tendon rupture and tendinopathy.
    Melhus A; Apelqvist J; Larsson J; Eneroth M
    Scand J Infect Dis; 2003; 35(10):768-70. PubMed ID: 14606622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
    Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin revisited.
    Med Lett Drugs Ther; 2011 Jul; 53(1368):55. PubMed ID: 21738109
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
    Adelglass J; Jones TM; Ruoff G; Kahn JB; Wiesinger BA; Rielly-Gauvin K; Siu CO
    Pharmacotherapy; 1998; 18(6):1255-63. PubMed ID: 9855324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral levofloxacin in the treatment of community-acquired pneumonia.
    Nicodemo AC; Lima Nicodemo E; Idrahim KY
    Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactoid reaction to levofloxacin.
    Smythe MA; Cappelletty DM
    Pharmacotherapy; 2000 Dec; 20(12):1520-3. PubMed ID: 11130225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolone drug rash in a patient with infectious mononucleosis.
    Paily R
    J Dermatol; 2000 Jun; 27(6):405-6. PubMed ID: 10920588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections.
    Burgmann H; Mayer B; Lukas A; Kumbein F; Oberbauer R
    Wien Med Wochenschr; 2003; 153(7-8):156-62. PubMed ID: 12764869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone-induced tendinopathy: also occurring with levofloxacin.
    Fleisch F; Hartmann K; Kuhn M
    Infection; 2000; 28(4):256-7. PubMed ID: 10961538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.